Photobiomodulation, or PBM, uses low-level red and near-infrared light to influence cellular energy production. In ophthalmology, it's being studied most seriously for retinal conditions like dry age-related macular degeneration, where mitochondrial stress in the retina and RPE plays a central role. In this episode, Dr. Saikumar Gandapodi walks through the biology — how light interacts with cytochrome c oxidase, why the retina is uniquely metabolically demanding, and what recent human trials do and don't tell us.

We separate the established from the emerging at every turn. Dr. Gandapodi is candid about the limits: PBM is not a cure, dosing is still being worked out, and much of the mechanistic story comes from lab and animal models. He also explains how PBM fits into an integrative, whole-person framework at Netra Eye Institute — always as an adjunct to standard ophthalmic care, never a replacement.

This is a research-driven conversation for anyone curious about where light-based therapy is genuinely heading in eye medicine, and how to think critically about early but promising science.

Where systems biology, root-cause thinking, and standard eye care meet.

What does it actually mean to practice integrative ophthalmology, and how is it different from the eye care most patients already know? In this episode, Dr. Saikumar Gandapodi, Board-Certified Doctor of Oriental Medicine, Ayurvedic practitioner, and Founder of Netra Eye Institute, sits down to define an emerging clinical discipline that treats the eye as part of the whole body rather than an isolated organ.

We explore where conventional ophthalmology excels, where chronic eye disease leaves gaps, and how concepts like ocular blood flow, oxidative stress, inflammation, and the gut-eye axis are being studied as contributors to disease. Dr. Gandapodi explains Netra Restoration Therapy as a multi-target, adjunctive approach, and he is candid throughout about what is established versus what remains early and hypothesis-generating.

This is a research-driven conversation for an educated audience curious about the future of eye health, told without hype and without dismissing the surgery and pharmaceuticals that save sight every day.

Age-related macular degeneration is usually described as a problem of aging and drusen. But a growing body of research points to something deeper: a slow failure of energy metabolism in the retina and the cells that support it. In this episode, Dr. Saikumar Gandapodi, Founder and Director of Netra Eye Institute, reframes AMD as a disease of metabolic exhaustion in the retinal pigment epithelium and photoreceptors.

We explore why the macula is metabolically the most demanding tissue in the body, how mitochondrial dysfunction, oxidative stress, and lipid handling failures set the stage for drusen and cell death, and what conventional care does well. Dr. Gandapodi explains the evidence behind anti-VEGF therapy and the AREDS trials, and where meaningful gaps remain.

He also introduces Netra Restoration Therapy, an integrative, adjunct approach aimed at supporting mitochondrial function, oxidative balance, and ocular blood flow. Throughout, the conversation stays honest about what is established, what is emerging, and what remains hypothesis.